Abstract:Objective: To investigate the effects of 15-deoxy-prostaglandin J2 (15d-PGJ2), a peroxisome proliferatoractivated receptor γ (PPARγ) endogenous ligand, on proliferation and apoptosis of human HepG2 cells and to explore the potential mechanism. Methods: 15d-PGJ2 at different concentrations was used to treat the HepG2 cells cultured in vitro, MTT colorimetry was employed to measure proliferation of the cells, and 3H-TdR uptake test was used to measure the synthetic rate of the cells. The expressions of PPARγ mRNA and protein were measured by reverse transcription-polymerase chain reaction (RT-PCR) and western blot. Cell apoptosis rate and cell cycle were analyzed by flow cytometry (FCM). And the effects of PPARγ-specific antagonist (GW9662) and/or transient transfection pSG5-PPARγ eukaryotic expression plasmid on proliferation of the HepG2 cells were also observed, and pGCsi-PPARγ was used to transfect the cells to observe the effects of 15d-PGJ2 on proliferation of the HepG2 cells in the silence of PPARγ. The DNA binding activity of NF-κB was detected by electrophoretic mobility shift assay (EMSA). Results: 15d-PGJ2 at different concentrations inhibited cell proliferation, DNA synthetic rate and induced apoptosis in a dose-dependent manner in HepG2 cells; in this process, the proportion of G0/G1 phase cells increased significantly while the proportion of S phase cells decreased significantly, and the expression levels of PPARγ mRNA and protein were not changed. GW9662 antagonized the proliferation inhibition effect of 15d-PGJ2, but didn’t block completely. However, transfection with a PPARγ-pSG5 expression plasmid restored the effect of 15d-PGJ2 on cell growth in presence of GW9662. After transfection with pGCsi-PPARγ, 15d-PGJ2 also inhibited cell proliferation at 20 μmol·L-1. Furthermore, 15d-PGJ2 inhibited the DNA binding activity of NF-κB at a higher concentration (50 μmol·L -1). Conclusion: 15d-PGJ2 inhibits cell growth, induces apoptosis and interferes with cell cycle of the HepG2 cells, which indicates that the activation of PPARγ is anti-neoplastic in HCC. This effect involves the PPARγ-dependent and PPARγ-independent pathways, which is related to the inhibition of NF-κB signaling pathway.

Xeroderma Pigmentosum group D suppresses proliferation and promotes apoptosis of HepG2 cells by downregulating ERG expression via the PPARγ pathway

PEG10 Directly Regulated by E2Fs Might Have a Role in the Development of Hepatocellular Carcinoma.

ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway

Effects and mechanism of 15-deoxy-prostaglandin J 2 on proliferation and apoptosis of human HepG 2 cells

PPARγ Coactivator‐1α Suppresses Metastasis of Hepatocellular Carcinoma by Inhibiting Warburg Effect by PPARγ–Dependent WNT/β‐Catenin/Pyruvate Dehydrogenase Kinase Isozyme 1 Axis

Enoyl-coenzyme A Hydratase, Short Chain 1 Involved in Promoting the Proliferation of Hepatocellular Carcinoma HepG2 Cells

Overexpression of Xeroderma Pigmentosum Group C Decreases the Chemotherapeutic Sensitivity of Colorectal Carcinoma Cells to Cisplatin

The PGC1α/NRF1-MPC1 axis suppresses tumor progression and enhances the sensitivity to sorafenib/doxorubicin treatment in hepatocellular carcinoma

Growth Arrest-Specific Gene 2 Suppresses Hepatocarcinogenesis by Intervention of Cell Cycle and P53-Dependent Apoptosis

Recruited Metastasis Suppressor NM23-H2 Attenuates Expression and Activity of Peroxisome Proliferator-Activated Receptor Δ (pparδ) in Human Cholangiocarcinoma.

Heat Shock Protein Gp96 Decreases P53 Stability by Regulating Mdm2 E3 Ligase Activity in Liver Cancer.

Xanthine Dehydrogenase Downregulation Promotes TGFβ Signaling and Cancer Stem Cell-Related Gene Expression in Hepatocellular Carcinoma

Downregulation of GPX8 in Hepatocellular Carcinoma: Impact on Tumor Stemness and Migration.

Sel1L-Hrd1 ER-Associated Degradation Suppresses Hepatocyte Hyperproliferation and Liver Cancer

HBV Suppresses Thapsigargin-Induced Apoptosis Via Inhibiting CHOP Expression in Hepatocellular Carcinoma Cells.

Loss of Xiap Sensitizes Colon Cancer Cells to Ppar Gamma Independent Antitumor Effects of Troglitazone and 15-Pgj2

P53 Promotes Proteasome-Dependent Degradation of Oncogenic Protein HBx by Transcription of MDM2.

Role of the XPC Gene Expression in the Prevention of Oxidative and DNA Damage to Lung Squamous Carcinoma Cells

CYP2E1 plays a suppressive role in hepatocellular carcinoma by regulating Wnt/Dvl2/β-catenin signaling

MECP2 Promotes Cell Proliferation by Activating ERK1/2 and Inhibiting P38 Activity in Human Hepatocellular Carcinoma HEPG2 Cells.

NOP2-mediated m5C methylation of XPD is associated with hepatocellular carcinoma progression